Overview
Germ cell tumors (GCTs) are a heterogeneous group of neoplasms that arise from primordial germ cells, the precursor cells that normally develop into eggs or sperm. These tumors can occur in the gonads (ovaries or testes) or in extragonadal sites along the midline of the body, including the mediastinum, retroperitoneum, sacrococcygeal region, and central nervous system (particularly the pineal gland and suprasellar region). GCTs encompass several histological subtypes, including germinomas (seminomas/dysgerminomas), yolk sac tumors (endodermal sinus tumors), embryonal carcinomas, choriocarcinomas, teratomas (mature and immature), and mixed germ cell tumors. They can be benign or malignant. Clinical presentation varies depending on the tumor location and subtype. Gonadal GCTs may present as a painless testicular mass in males or an ovarian mass causing abdominal pain, distension, or menstrual irregularities in females. Extragonadal tumors may cause symptoms related to mass effect, such as respiratory distress (mediastinal tumors), neurological symptoms including diabetes insipidus and visual disturbances (intracranial tumors), or bowel and bladder dysfunction (sacrococcygeal tumors). Many GCTs produce tumor markers, including alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (beta-hCG), which are valuable for diagnosis and monitoring treatment response. Treatment depends on tumor type, location, and stage, and typically involves a combination of surgical resection and platinum-based chemotherapy (most commonly bleomycin, etoposide, and cisplatin — the BEP regimen). Radiation therapy may be used for certain subtypes, particularly intracranial germinomas, which are highly radiosensitive. Overall, GCTs are among the most curable solid tumors, with cure rates exceeding 90% for many subtypes when treated appropriately. Risk factors include cryptorchidism (undescended testes), disorders of sex development, and certain genetic conditions such as Klinefelter syndrome. While most cases are sporadic, familial clustering has been observed, particularly in testicular GCTs, suggesting a multifactorial genetic contribution.
Multifactorial
Caused by a mix of several genes and environmental factors
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
10 eventsCoherence Neuro Australia Pty Limited — NA
Indiana University — NA
Tata Memorial Hospital — PHASE2
Peking University Cancer Hospital & Institute
Minia University
Iovance Biotherapeutics, Inc. — PHASE2
Novelwise Pharmaceutical Corporation — PHASE1, PHASE2
Eastern Cooperative Oncology Group — PHASE2
AstraZeneca — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Germ cell tumor.
5 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBanner University Medical Center - Tucson
📍 Tucson, Arizona
Kingman Regional Medical Center
📍 Kingman, Arizona
PCR Oncology
📍 Arroyo Grande, California
University of Arizona Cancer Center-North Campus
📍 Tucson, Arizona
Mercy Hospital Fort Smith
📍 Fort Smith, Arkansas
Kaiser Permanente-Deer Valley Medical Center
📍 Antioch, California
Kaiser Permanente-Anaheim
📍 Anaheim, California
Kaiser Permanente-Baldwin Park
📍 Baldwin Park, California
Travel Grants
No travel grants are currently matched to Germ cell tumor.
Community
No community posts yet. Be the first to share your experience with Germ cell tumor.
Start the conversation →Latest news about Germ cell tumor
Disease timeline:
New recruiting trial: 18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma
A new clinical trial is recruiting patients for Germ cell tumor
New recruiting trial: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
A new clinical trial is recruiting patients for Germ cell tumor
New recruiting trial: Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
A new clinical trial is recruiting patients for Germ cell tumor
New recruiting trial: Mapping of Electrical Properties in the Brain
A new clinical trial is recruiting patients for Germ cell tumor
New recruiting trial: 5G-EMERALD: Amivantamab in Malignant Brain Tumours
A new clinical trial is recruiting patients for Germ cell tumor
New recruiting trial: The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
A new clinical trial is recruiting patients for Germ cell tumor
New recruiting trial: Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
A new clinical trial is recruiting patients for Germ cell tumor
New recruiting trial: Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma
A new clinical trial is recruiting patients for Germ cell tumor
New recruiting trial: Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy
A new clinical trial is recruiting patients for Germ cell tumor
New recruiting trial: Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
A new clinical trial is recruiting patients for Germ cell tumor
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Germ cell tumor
What is Germ cell tumor?
Germ cell tumors (GCTs) are a heterogeneous group of neoplasms that arise from primordial germ cells, the precursor cells that normally develop into eggs or sperm. These tumors can occur in the gonads (ovaries or testes) or in extragonadal sites along the midline of the body, including the mediastinum, retroperitoneum, sacrococcygeal region, and central nervous system (particularly the pineal gland and suprasellar region). GCTs encompass several histological subtypes, including germinomas (seminomas/dysgerminomas), yolk sac tumors (endodermal sinus tumors), embryonal carcinomas, choriocarcinom
How is Germ cell tumor inherited?
Germ cell tumor follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Are there clinical trials for Germ cell tumor?
Yes — 5 recruiting clinical trials are currently listed for Germ cell tumor on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Germ cell tumor?
25 specialists and care centers treating Germ cell tumor are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.